Imaging of myocardial fatty acid oxidation

Kieren Mather, Timothy R. DeGrado

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Myocardial fuel selection is a key feature of the health and function of the heart, with clear links between myocardial function and fuel selection and important impacts of fuel selection on ischemia tolerance. Radiopharmaceuticals provide uniquely valuable tools for in vivo, non-invasive assessment of these aspects of cardiac function and metabolism. Here we review the landscape of imaging probes developed to provide non-invasive assessment of myocardial fatty acid oxidation (MFAO). Also, we review the state of current knowledge that myocardial fatty acid imaging has helped establish of static and dynamic fuel selection that characterizes cardiac and cardiometabolic disease and the interplay between fuel selection and various aspects of cardiac function.This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk.

Original languageEnglish (US)
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
DOIs
StateAccepted/In press - Jan 21 2016

Fingerprint

Fatty Acids
Radiopharmaceuticals
Lipid Metabolism
Heart Diseases
Ischemia
Health

Keywords

  • Fatty acid oxidation
  • Fatty acid uptake
  • Metabolic imaging
  • Myocardial metabolism
  • PET
  • SPECT

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Imaging of myocardial fatty acid oxidation. / Mather, Kieren; DeGrado, Timothy R.

In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 21.01.2016.

Research output: Contribution to journalArticle

@article{1446233cb0c24baf83fe3da10476844c,
title = "Imaging of myocardial fatty acid oxidation",
abstract = "Myocardial fuel selection is a key feature of the health and function of the heart, with clear links between myocardial function and fuel selection and important impacts of fuel selection on ischemia tolerance. Radiopharmaceuticals provide uniquely valuable tools for in vivo, non-invasive assessment of these aspects of cardiac function and metabolism. Here we review the landscape of imaging probes developed to provide non-invasive assessment of myocardial fatty acid oxidation (MFAO). Also, we review the state of current knowledge that myocardial fatty acid imaging has helped establish of static and dynamic fuel selection that characterizes cardiac and cardiometabolic disease and the interplay between fuel selection and various aspects of cardiac function.This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk.",
keywords = "Fatty acid oxidation, Fatty acid uptake, Metabolic imaging, Myocardial metabolism, PET, SPECT",
author = "Kieren Mather and DeGrado, {Timothy R.}",
year = "2016",
month = "1",
day = "21",
doi = "10.1016/j.bbalip.2016.02.019",
language = "English (US)",
journal = "Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids",
issn = "1388-1981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Imaging of myocardial fatty acid oxidation

AU - Mather, Kieren

AU - DeGrado, Timothy R.

PY - 2016/1/21

Y1 - 2016/1/21

N2 - Myocardial fuel selection is a key feature of the health and function of the heart, with clear links between myocardial function and fuel selection and important impacts of fuel selection on ischemia tolerance. Radiopharmaceuticals provide uniquely valuable tools for in vivo, non-invasive assessment of these aspects of cardiac function and metabolism. Here we review the landscape of imaging probes developed to provide non-invasive assessment of myocardial fatty acid oxidation (MFAO). Also, we review the state of current knowledge that myocardial fatty acid imaging has helped establish of static and dynamic fuel selection that characterizes cardiac and cardiometabolic disease and the interplay between fuel selection and various aspects of cardiac function.This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk.

AB - Myocardial fuel selection is a key feature of the health and function of the heart, with clear links between myocardial function and fuel selection and important impacts of fuel selection on ischemia tolerance. Radiopharmaceuticals provide uniquely valuable tools for in vivo, non-invasive assessment of these aspects of cardiac function and metabolism. Here we review the landscape of imaging probes developed to provide non-invasive assessment of myocardial fatty acid oxidation (MFAO). Also, we review the state of current knowledge that myocardial fatty acid imaging has helped establish of static and dynamic fuel selection that characterizes cardiac and cardiometabolic disease and the interplay between fuel selection and various aspects of cardiac function.This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk.

KW - Fatty acid oxidation

KW - Fatty acid uptake

KW - Metabolic imaging

KW - Myocardial metabolism

KW - PET

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84959543318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959543318&partnerID=8YFLogxK

U2 - 10.1016/j.bbalip.2016.02.019

DO - 10.1016/j.bbalip.2016.02.019

M3 - Article

C2 - 26923433

AN - SCOPUS:84959543318

JO - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

JF - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

SN - 1388-1981

ER -